Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of HLA antibody screening and treatment to prevent chronic renal allograft rejection
2012-004308-36Phase 4Unknown
- Sponsor
- King's College London
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone, tacrolimus, mycophenolic acid, mycophenolate mofetil, mycophenolate sodium in kidney allograft rejection, Chronic humoral rejection (cABMR), sponsored by King's College London. Status: unknown.
02
Drugs
prednisolonetacrolimusmycophenolic acidmycophenolate mofetilmycophenolate sodium
03
Conditions
kidney allograft rejectionChronic humoral rejection (cABMR)
Beyond the preview
Go deeper on 2012-004308-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004308-36.